Meriwether Wealth & Planning’s Novo Nordisk NVO Stock Holding History

Meriwether Wealth & Planning’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$3.15K	Buy	+83	New	+$3.83K	﹤0.01%	583

Other funds holding NVO

Saratoga Research & Investment Management Saratoga, California $1.82B AUM 11.8% 1-Year Est. Return

Oppenheimer Asset Management New York $9.5B AUM 23.46% 1-Year Est. Return

Euro Pacific Asset Management Dorado, Puerto Rico $1.22B AUM 22.48% 1-Year Est. Return

Nichols & Pratt Advisers Boston, Massachusetts $1.68B AUM 20.22% 1-Year Est. Return

Corda Investment Management Houston, Texas $1.52B AUM 30.53% 1-Year Est. Return

GuoLine Advisory Singapore $1.16B AUM 31.35% 1-Year Est. Return

Philip James Wealth Mangement Milton, Georgia $906M AUM 30.39% 1-Year Est. Return

QV Investors Calgary, Alberta, Canada $1.36B AUM 20.86% 1-Year Est. Return

Cantor Fitzgerald Investment Advisors New York $1.81B AUM 23.74% 1-Year Est. Return

Penbrook Management New York $169M AUM 32.52% 1-Year Est. Return

Meriwether Wealth & Planning's NVO Position: Q3 2026 in Review

Meriwether Wealth & Planning opened a new position in Novo Nordisk (NVO) in Q3 2026: 83 shares worth $3.15K. The stake represents ﹤0.01% of the portfolio and ranks #583 among its holdings.

410 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

Meriwether Wealth & Planning held 83 shares of Novo Nordisk worth $3.15K as of Q3 2026.
Novo Nordisk was a new Meriwether Wealth & Planning position in Q3 2026.
Novo Nordisk made up ﹤0.01% of Meriwether Wealth & Planning's portfolio in Q3 2026, its #583 holding.
410 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on Meriwether Wealth & Planning's 13F filing for Q3 2026, filed 13 Oct 2026.